Precisely tracking childhood death by Farag, Tamer H. et al.
Am. J. Trop. Med. Hyg., 97(1), 2017, pp. 3–5
doi:10.4269/ajtmh.16-0302
Copyright © 2017 by The American Society of Tropical Medicine and Hygiene
Perspective Piece
Precisely Tracking Childhood Death
Tamer H. Farag,1* Jeffrey P. Koplan,2,3 Robert F. Breiman,2 Shabir A. Madhi,4 Penny M. Heaton,1 Trevor Mundel,1
Jaume Ordi,5,6 Quique Bassat,5,7,8 Clara Menendez,5,7 and Scott F. Dowell1
1Bill & Melinda Gates Foundation, Seattle, Washington; 2Emory Global Health Institute, Atlanta, Georgia; 3International Association of
National Public Health Institutes, Atlanta, Georgia; 4National Institute for Communicable Diseases, National Health Laboratory Service,
Johannesburg, South Africa; 5ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clı´nic, Universitat de Barcelona,
Barcelona, Spain; 6Department of Pathology, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain; 7Centro de Investigação em
Sau´de de Manhiça (CISM), Maputo, Mozambique; 8Institucio´ Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
Abstract. Little is known about the speciﬁc causes of neonatal and under-ﬁve childhood death in high-mortality
geographic regions due to a lack of primary data and dependence on inaccurate tools, such as verbal autopsy.
Tomeet the ambitious newSustainable Development Goal 3.2 to eliminate preventable childmortality in every country,
better approaches are needed to precisely determine speciﬁc causes of death so that prevention and treatment
interventions can be strengthened and focused. Minimally invasive tissue sampling (MITS) is a technique that uses
needle-based postmortem sampling, followed by advanced histopathology and microbiology to deﬁnitely determine
cause of death. The Bill & Melinda Gates Foundation is supporting a new surveillance system called the Child Health
and Mortality Prevention Surveillance network, which will determine cause of death using MITS in combination with
other information, and yield cause-speciﬁc population-based mortality rates, eventually in up to 12–15 sites in sub-
Saharan Africa and south Asia. However, the Gates Foundation funding alone is not enough. We call on governments,
other funders, and international stakeholders to expand the use of pathology-based cause of death determination to
provide the information needed to end preventable childhood mortality.
Although global childhood mortality has dropped by half
since 1990, it remains unacceptable that in 2015, one of every
20 children dies before 5 years of age. As the rates have de-
creased, in association with improved vaccine coverage,
better health-care access, and malaria control, the remaining
deaths occur disproportionately among neonates, which now
account for 40–45% of childhood deaths, and in countries in
parts of Africa and south Asia, where childhoodmortality rates
approach one in every 10 children.1–4 Surviving the neonatal
period is becoming increasingly important to guarantee child
survival, as the proportion of under-ﬁve deaths occurring in
this period will continue to increase in relation to global child
mortality reductions. The causesof neonatal deaths are poorly
understood; thus, few interventions have been ﬁelded against
them. Verbal autopsies, a primary basis for estimating causes
of death, discriminate most syndromes poorly, particularly in
the neonatal period, and cannot identify causal pathogens,
casting doubt over estimates used to focus, strategize, and
measure progress.5,6 In the highest mortality regions in sub-
Saharan Africa and south Asia, even verbal autopsy data are
largely unavailable. For example, Global Burden of Disease
estimates for cause-speciﬁc childhood mortality in the Demo-
cratic Republic of the Congo are modeled from two verbal
autopsystudiespublished in1989and1993, andonehousehold
survey based on report from the head of household (not verbal
autopsy), published in 2006.7 Continued reliance on such data,
coupled with increasing sophistication of modeling methods
used, risks creating a false sense of assuredness regardingwhat
is known about the causes of childhood mortality.
The United Nations has recently adopted ambitious Sus-
tainable Development Goals, including the “end of preventable
deaths of newborns and children under 5 years of age” by
2030.8 To realistically achievesuchgoals, theglobal community
cannot continue to rely on uncertain, unrepresentative, and
untimely mortality data. Deliberately implemented, more rigor-
ous surveillance is needed to provide accurate information on
causes of death, based on pathology specimens from children
who have died. The ﬁndings must then be shared as soon
as possible with families, government agencies, and global
stakeholders.6 A novel approach, minimally invasive tissue
sampling (MITS), builds on postmortem needle biopsies of tis-
sue that have been in occasional use for disease-speciﬁc sur-
veillance and outbreak investigations for decades. Innovative
approaches have yielded rapid recognition of MITS as a com-
prehensive tool to obtain postmortem samples in challenging
settings, demonstrating agreement with complete diagnostic
autopsy in some 70–90% of cases.9,10 Preliminary results of
a research project to validate MITS against gold standard
methods in Mozambique and Brazil have shown that MITS has
highagreementwith, andcan reliablysubstitute for, full autopsy,
particularly for infectious causes of death.11 Over the past
18 months, MITS has been performed in an array of countries
including Bangladesh, Brazil, Kenya, Mozambique, and South
Africa, and has been acceptable to families. A multicountry
anthropological research study has found good theoretical
acceptability and willingness to know cause of death in the
community.12 A recently completed hospital-based post-
mortem investigation in Soweto conducted among 365 still-
births from June 2015 to September 2015, identiﬁed Group B
Streptococcus to be deﬁnitely associated with 5% of the still-
births and possibly related to a further 15%. This novel ﬁnding
has the potential to change national policy in management
and intervention in pregnant women to reduce a previously
unrecognized, but potentially preventable cause of stillbirth.
(S. A. Madhi, personal communication).
To address the problems of validity, timeliness, and re-
gional representation described above, the Bill & Melinda
* Address correspondence to Tamer H. Farag, Institute for Health
Metrics and Evaluation, 2301 5th Avenue, Suite 600, Seattle, WA
98121. E-mail: faragt@uw.edu
3
Gates Foundation is funding the Child Health and Mortality
Prevention Surveillance (CHAMPS) network. Coordinated
by Emory University in association with the International
Association of National Public Health Institutes, U.S.Centers
for Disease Control and Prevention, and the Public Health
Informatics Institute of the Task Force for Global Health,
CHAMPS aims to more deﬁnitively determine the causes
of childhood mortality in the highest-mortality regions of
sub-Saharan Africa and south Asia, eventually including
12–15 sites. Each site will determine the causes of child-
hood death using MITS, in combination with conducting
verbal autopsies and medical record abstractions, within
demographically deﬁned populations, producing ongoing
cause-speciﬁc childhood mortality rates. Comprehensive an-
thropological work will be conducted to promote community
engagement and sensitization, to increase the likelihood
that MITS is welcomed by the communities and health-care
providers, as well as religious, cultural, and political leaders.13
Ministry of Health and/or National Public Health Institute
staff at each CHAMPS site will be engaged in implementa-
tion, analyses, and reporting to maximize the utility of evi-
dence derived from CHAMPS for public health policy
decision-making and local laboratory and pathology ca-
pacity will be built and supported to enable long-term sus-
tainability and expansion. Protocols will be standardized
across sites, and data will be uploaded to cloud-based
servers for rapid dissemination to host governments and
global stakeholders, such as the United Nations Children’s
Emergency Fund, World Health Organization, The World
Bank, and disease burden expert groups. CHAMPSwill seek
to integrate with existing surveillance by aligning protocols
and combining data with complementary systems, such as
Sample Registration Systems14 and health management
information systems to provide a current, comprehensive,
and statistically valid view of childhood mortality. Six sites
have been selected, and the ﬁrst MITS data began ﬂowing
in January 2017.
Although we advocate MITS whenever possible for cause
of death determination, we recognize that verbal autopsy
and medical certiﬁcation will remain more widely used be-
cause they can be donewith less training and inexpensively—
when MITS and verbal autopsy/medical certiﬁcation are
combined, they can provide more precise and statistically
valid estimates of causes of death across all geographies
of a country.6,15 Indeed, the recently funded Countrywide
Mortality Surveillance for Action initiative in Mozambique
will measure mortality across the country using represen-
tative sampling with verbal autopsy that is supplemented by
MITS-based cause of death data from the CHAMPS site in
Manhiça, aswell as selected additionalMITS in other parts of
the country. We hope that this system can serve as a model
for sample registration system solutions to civil registration
and vital statistics (CRVS) in response to the global call for
development and strengthening of CRVS.16
No child should die of a preventable cause in the new mil-
lennium. Pathology-based surveillance offers the potential
for more accurately tracking the causes of death, enabling
policymakers to match this information with precision public
health strategies, applying policies that are speciﬁc, impact-
ful, and responsive to changing epidemiology.15 We hope
that CHAMPS will kindle a wide-scale demand and multi-
faceted ﬁnancial support for strengthening public health
systems to identify and tackle substantive contributors to
unacceptably high death rates. However, Gates Foundation
funding alone will not be enough to enable these outcomes.
We encourage expanded use of surveillance linked to
pathology-based cause of death determination at local, na-
tional, and global levels to provide the information needed to
end preventable childhood mortality.
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